Aigen Sciences

Seoul, South Korea · Founded 2021 · Privately Held (backing)

Operator of an artificial intelligence (AI) based new drug development platform intended to discover high-potency drugs. Aigen Sciences is based in Seoul, South Korea and was founded in 2021. It has raised $12 million.

Last price · $/share

—

Implied valuation

—

Total raised

$12.0M

Last round

—

How much has Aigen Sciences raised?

$12.0Macross 0 recorded rounds

Free account

More of Aigen Sciences with a free account

·The complete investor list: 11 names
·Watch Aigen Sciences: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Aigen Sciences investors

11 investors are on record for Aigen Sciences, including Partners Investment, Premier Partners, Bluepoint Partners and K2 Investment Partners. By type, the record holds 4 venture capital firms, 1 hedge fund and 1 private equity firm.

For fundraisers

Raising for a company like Aigen Sciences?

11 investors have backed Aigen Sciences.

See all 11 investors →

Frequently asked about Aigen Sciences

How much has Aigen Sciences raised?: Aigen Sciences has raised $12.0M in total across 0 recorded funding rounds.